FDA Inspection 1193360 — The American National Red Cross

The American National Red Cross — FEI 1077596

The FDA completed an inspection of The American National Red Cross on December 7, 2022 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 7, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wilmington, NC (United States)